Lung Cancer Clinical Trial 2014-083CIRB

[LCID Study Number: 2014-083CIRB]

A151216: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

The purpose of this study is to examine lung cancer patients’ surgically removed tumors for certain genetic changes, and to possibly refer these patients to a treatment study with drugs that may specifically target tumors that have these genetic changes.

Disease/Condition: Lung Cancer

Department: Hematology and Oncology

Location(s): Lahey Hospital & Medical Center (Burlington), Lahey Medical Center, Peabody; Lahey Lexington, Lahey Arlington, Lahey Nashua

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421

View NCT ID 02194738 on ClinicalTrials.gov
Protocol #: 2014-083CIRB
Principal Investigator(s): Paul J Hesketh
Study Coordinator(s): Julia Roache
Trial Phase: Sponsor Initiated Study Phase 3